StreetInsider.com News Articles

TRexBio prices IPO at $14 per share on Nasdaq

Thu, 08 Oct 2026 21:29:28 -0400

TRex Bio, Inc. (Nasdaq: TRXB), a clinical-stage biotechnology company, priced its initial public offering of 8,333,334 shares of common stock at $14.00 per share, according to a press release statement.

The gross proceeds from the offering are expected to be approximately $116.7 million before deducting underwriting discounts, commissions, and other expenses. All shares are being offered by TRexBio.

The company's common stock was expected to begin trading on the Nasdaq Global Select Market on Oct. 9, 2026, under the ticker symbol "TRXB," with the offering expected to close on Oct. 13, 2026, subject to customary closing conditions.

TRexBio has also granted underwriters a

TRexBio prices IPO at $14 per share on Nasdaq

Thu, 08 Oct 2026 21:29:28 -0400

The gross proceeds from the offering are expected to be approximately $116.7 million before deducting underwriting discounts, commissions, and other expenses. All shares are being offered by TRexBio.

TRexBio has also granted underwriters a

TRexBio Announces Pricing of Initial Public Offering

Thu, 08 Oct 2026 21:29:00 -0400

SOUTH SAN FRANCISCO, Calif., Oct. 08, 2026 (GLOBE NEWSWIRE) -- TRex Bio, Inc. (“TRexBio”) (Nasdaq: TRXB), a clinical-stage biotechnology company focused on tissue Treg biology for the discovery and development of immunoregulatory medicines, today announced the pricing of its initial public offering of 8,333,334 shares of its common stock at an initial public offering price of $14.00 per share. All of the shares are being offered by TRexBio. The gross proceeds from the offering, before deducting underwriting discounts and commissions and other offering expenses, are expected to be approximately $116.7 million. TRexBio’s common stock is expected to

TRexBio Announces Pricing of Initial Public Offering

Thu, 08 Oct 2026 21:29:00 -0400

TRex Bio (TRXB) files for 8.33M share IPO at $14-$16/sh

Mon, 05 Oct 2026 06:35:23 -0400

TRex Bio on Monday filed for a 8,333,334 share Nasdaq IPO at $14-$16 per share.

TRex Bio (TRXB) files for 8.33M share IPO at $14-$16/sh

Mon, 05 Oct 2026 06:35:23 -0400

TRex Bio on Monday filed for a 8,333,334 share Nasdaq IPO at $14-$16 per share.